Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial

The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Read this story here.

Om Podcasten

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.